Serena Vella

1.3k total citations
32 papers, 1.0k citations indexed

About

Serena Vella is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Serena Vella has authored 32 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Serena Vella's work include Cancer therapeutics and mechanisms (7 papers), Neuroblastoma Research and Treatments (5 papers) and MicroRNA in disease regulation (4 papers). Serena Vella is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Neuroblastoma Research and Treatments (5 papers) and MicroRNA in disease regulation (4 papers). Serena Vella collaborates with scholars based in Italy, United States and Netherlands. Serena Vella's co-authors include Aldo Pagano, Ranieri Cancedda, Pier Giulio Conaldi, Elisa Tavanti, Claudia Maria Hattinger, Marilù Fanelli, Massimo Serra, Tullio Florio, Piero Picci and Claudio Russo and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Serena Vella

32 papers receiving 1.0k citations

Peers

Serena Vella

ONCOL

PHYSI

PRM

Daniela Annibali Belgium

Hark Kyun Kim South Korea

Manjusha Dixit India

Vito D’Agostino Italy

Shuping Li China

Gabriela Schneider United States

Shenqi Zhang China

Heng Liu China

Chia‐Yi Su Taiwan

Françoise Frérart Belgium

Daniela Annibali Belgium

Serena Vella

601 ×0.9

257 ×0.7

295 ×2.0

ONCOL

55 ×0.5

PHYSI

104 ×1.1

PRM

Citations per year, relative to Serena Vella Serena Vella (= 1×) peers Daniela Annibali

Countries citing papers authored by Serena Vella

Since Specialization

Citations

This map shows the geographic impact of Serena Vella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serena Vella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serena Vella more than expected).

Fields of papers citing papers by Serena Vella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serena Vella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serena Vella. The network helps show where Serena Vella may publish in the future.

Co-authorship network of co-authors of Serena Vella

This figure shows the co-authorship network connecting the top 25 collaborators of Serena Vella. A scholar is included among the top collaborators of Serena Vella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serena Vella. Serena Vella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Russo, Tiziana, et al.. (2024). Electrospray Fabrication of pH‐Responsive Microspheres for the Delivery of Ozoile. Macromolecular Symposia. 413(4). 5 indexed citations

Cermola, Flavio, Serena Vella, Marina DellaGreca, Angela Tuzi, & Maria Rosaria Iesce. (2021). A One-Pot Approach to Novel Pyridazine C-Nucleosides. Molecules. 26(8). 2341–2341. 4 indexed citations

Brizzolara, Antonella, Serena Vella, Alessandro Quattrone, et al.. (2020). Co-Administration of Fendiline Hydrochloride Enhances Chemotherapeutic Efficacy of Cisplatin in Neuroblastoma Treatment. Molecules. 25(22). 5234–5234. 6 indexed citations

Fanelli, Marilù, Elisa Tavanti, Maria Pia Patrizio, et al.. (2020). Cisplatin Resistance in Osteosarcoma: In vitro Validation of Candidate DNA Repair-Related Therapeutic Targets and Drugs for Tailored Treatments. Frontiers in Oncology. 10. 331–331. 35 indexed citations

Gallo, Alessia, Serena Vella, Fabio Tuzzolino, et al.. (2019). MicroRNA-mediated Regulation of Mucin-type O-glycosylation Pathway: A Putative Mechanism of Salivary Gland Dysfunction in Sjögren Syndrome. The Journal of Rheumatology. 46(11). 1485–1494. 10 indexed citations

Vella, Serena, Pier Giulio Conaldi, Emanuela Cova, et al.. (2018). Lung resident mesenchymal cells isolated from patients with the Bronchiolitis Obliterans Syndrome display a deregulated epigenetic profile. Scientific Reports. 8(1). 11167–11167. 9 indexed citations

Martini, Daniela, Alessia Gallo, Serena Vella, et al.. (2017). Cystatin S—a candidate biomarker for severity of submandibular gland involvement in Sjögren’s syndrome. Lara D. Veeken. 56(6). 1031–1038. 24 indexed citations

Vella, Serena, Pier Giulio Conaldi, Tullio Florio, & Aldo Pagano. (2016). PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic Drugs. PPAR Research. 2016. 1–10. 19 indexed citations

Vella, Serena, Alessia Gallo, Antonio Lo Nigro, et al.. (2016). PIWI-interacting RNA (piRNA) signatures in human cardiac progenitor cells. The International Journal of Biochemistry & Cell Biology. 76. 1–11. 49 indexed citations

10.

Vella, Serena, Elisa Tavanti, Claudia Maria Hattinger, et al.. (2016). Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells. PLoS ONE. 11(11). e0166233–e0166233. 24 indexed citations

11.

Hattinger, Claudia Maria, Marilù Fanelli, Elisa Tavanti, et al.. (2015). Advances in emerging drugs for osteosarcoma. Expert Opinion on Emerging Drugs. 20(3). 495–514. 77 indexed citations

12.

Vella, Serena, Ilaria Penna, Luca Longo, et al.. (2015). Perhexiline maleate enhances antitumor efficacy of cisplatin in neuroblastoma by inducing over-expression of NDM29 ncRNA. Scientific Reports. 5(1). 18144–18144. 37 indexed citations

13.

Fanelli, Marilù, Claudia Maria Hattinger, Serena Vella, et al.. (2015). Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1^® can Overcome Drug Resistance in Osteosarcoma. Current Cancer Drug Targets. 16(3). 261–274. 47 indexed citations

14.

Tavanti, Elisa, Serena Vella, Claudia Maria Hattinger, et al.. (2014). Targeting polo-like kinase 1 by NMS-P937 in osteosarcoma cell lines inhibits tumor cell growth and partially overcomes drug resistance. Investigational New Drugs. 32(6). 1167–1180. 28 indexed citations

15.

Vella, Serena, Daniela Gnani, Annalisa Crudele, et al.. (2013). EZH2 Down-Regulation Exacerbates Lipid Accumulation and Inflammation in in Vitro and in Vivo NAFLD. International Journal of Molecular Sciences. 14(12). 24154–24168. 43 indexed citations

16.

Massone, Sara, Eleonora Ciarlo, Serena Vella, et al.. (2012). NDM29, a RNA polymerase III-dependent non coding RNA, promotes amyloidogenic processing of APP and amyloid β secretion. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1823(7). 1170–1177. 113 indexed citations

17.

Corsaro, Alessandro, Tullio Florio, Serena Vella, et al.. (2012). Differential toxicity, conformation and morphology of typical initial aggregation states of Aβ1-42 and Aβpy3-42 beta-amyloids. The International Journal of Biochemistry & Cell Biology. 44(11). 2085–2093. 42 indexed citations

18.

Thellung, Stefano, Alessandro Corsaro, Valentina Villa, et al.. (2011). Human PrP90-231-induced cell death is associated with intracellular accumulation of insoluble and protease-resistant macroaggregates and lysosomal dysfunction. Cell Death and Disease. 2(3). e138–e138. 28 indexed citations

19.

Gavazzo, Paola, Serena Vella, Carla Marchetti, et al.. (2011). Acquisition of neuron‐like electrophysiological properties in neuroblastoma cells by controlled expression of NDM29 ncRNA. Journal of Neurochemistry. 119(5). 989–1001. 28 indexed citations

20.

Vella, Serena, Matteo Conti, Roberta Tasso, Ranieri Cancedda, & Aldo Pagano. (2011). Dichloroacetate inhibits neuroblastoma growth by specifically acting against malignant undifferentiated cells. International Journal of Cancer. 130(7). 1484–1493. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact